MRD / Regn No. : THBC\23-24\05547 Date : 18/06/2026
Patient Name : Jyoti Agarwal Age & Gender : 55 Yrs. / Female
Contact No. : 9324298746 UHID :
Ht / Wt / BMI : 147 / 65.2 / 30.17 BP S / BP D : 157 / 96
Allergies : NONE Referred By :
   
Problem List : T2DM (13/Nov/2014) | HTN (13/Nov/2020) |
Subjective : T2DM SINCE 2014,HTN SINCE 2020,WAS MAINTAINING HBA1C AROUND 7.5% - NOW SLIGHT INCREASE,CAN WALK AT NIGHT AS VERY HOT IN DAY,RECENT MANGO CONSUMPTION
Objective : 17-JUN-2026 REPORTS,HBA1C-8.0%,ACR-437.25
Plan : ADDING ERITEL 40 MG  
S# Generic (Trade) Name Route Dosage Usage Duration
1 LINARES M 2.5+500 MG ORAL 1-0-1 ABF / AD
4 MTHS
2 TABLET TELMISARTAN (40MG) AND CILNIDIPINE (10MG)
ERITEL LN 40
ORAL 1-0-0 ABF
4 MTHS
3 TABLET DAPAGLIFLOZIN (10MG)
GLUXIT 10 MG
ORAL 1-0-0 BBF
4 MTHS
4 GLIMISAVE M2 ORAL 0-1-1 BL / BD
4 MTHS
5 TABLET TELMISARTAN 40MG
ERITEL 40 MG
ORAL 0-0-1 AD
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 18/Oct/2026
Tests Suggested For Next Visit : FBS / PPBS / HBA1C / URINE FOR ALBUMIN:CREAT RATIO > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: